Transposon Therapeutics
Transposon Therapeutics, Inc.
San Diego, United States · Founded 2020 · $9.7M raised
- Headquarters
- San Diego, California
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2B
- Website
- transposonrx.com
- Total Funding
- $9.7M
- Last Round
- $5.0M GrantJul 2025
- Rounds
- 2
About
Biotech company developing LINE-1 reverse transcriptase inhibitors including TPN-101 for rare neurological diseases such as PSP and ALS.
Summary
Transposon Therapeutics is a Biotech company based in San Diego, United States, founded in 2020. It has raised $9.7M in total across 2 rounds, most recently a $5.0M Grant round in Jul 2025. Investors include Alzheimer's Drug Discovery Foundation and Canaan Partners.
Tech & App Stack
2 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jul 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...